August 1, 2017 – Daiichi Sankyo, the manufacturer of top-selling Benicar, Benicar HCT, Azor and Tribenzor has agreed to a $300 million settlement for individuals who experienced GI injuries as a result of taking one of its blood pressure drugs prior to 5/17/2015.
Action must be taken by 8/23/17 in order to be considered for this settlement.
Individuals who believe they may qualify for this settlement need to contact an attorney immediately.
Under terms of the settlement agreement, only individuals who are signed with an attorney by August 23, 2017 and who meet a specified criteria will be included.
You may qualify for inclusion in this settlement if you took Benicar, Benicar HCT, Azor or Tribenzor after May 17, 2015, and you saw a medical professional for gastrointestinal symptoms/side effects such as:
- Chronic diarrhea
- Rapid and excessive weight loss
- Cardiovascular problems